Clinical Trial Update: Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.

View source ↗

Summary

Clinical trial update for metastatic/advanced renal cell carcinoma treated with sunitinib/axitinib; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• sunitinib/axitinib (sunitinib and axitinib)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Renal Cell | Status: COMPLETED | Results posted: 2022-02-18